The pharmacist-led intervention more than doubled the pharmacologic treatment rate for AUD in primary care.
The pharmacist-led intervention more than doubled the pharmacologic treatment rate for AUD in primary care.
A dedicated Pain Management CPS with a focus on addiction medicine provides significant clinical and financial value in the inpatient setting.
These findings provide a framework for the long-term evaluation of intervention programs and guiding health care resource allocation to reduce adolescent alcohol consumption.
Removal of transmucosal buprenorphine PA requirements for Kentucky Medicaid enrollees was associated with a significant immediate increase in buprenorphine dispensing for OUD treatment.
Emerging evidence suggests novel OAT induction strategies for fentanyl-related OUD are feasible and show a consistent direction toward positive clinical and safety outcomes.
No summary available
NAMI has relaunched its #Vote4MentalHealth campaign for the 2026 elections. This nonpartisan campaign is part of NAMI’s long-standing efforts to help people across the country understand that voting and mental health are closely intertwined and find the resources and information they need to cast their ballot. NAMI urges voters to take the pledge to #Vote4MentalHealth, which is a commitment to do one thing: understand how your vote impacts mental health.
This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. This blog explores opportunities in the pharmaceutical industry.
This study's findings suggest an association between fluoroquinolones and increased risk of panic attacks.
Toolkit with tips and guideline summaries on opioid use disorder: screening, diagnosis, withdrawal, medications for treatment, overdose prevention education/treatment, special populations, co-occurring disorders, harm reduction strategies, and references.
Join us for an industry showcase: Tardive Dyskinesia: Considerations in the Specialty Pharmacy Setting, supported by Teva Pharmaceuticals! Registration is free and open to the public!
The new platform provides for analyzing adverse event reports.
Psychiatric pharmacists can be effective members of the healthcare team because they treat the whole patient and understand medications beyond the scope of mental illness. Watch this video and learn more about the psychiatric pharmacy specialty!
No summary available
MHFA training in pharmacy professionals is an effective intervention to promote mental health support, increase awareness, reduce stigma, and equip participants to make linkages.
A meta-analysis of children and teens found social media use was tied to higher rates of depression, behavioral problems, self-injury, and substance use. (JAMA Pediatrics)
Rising temperatures could trigger over a billion additional "symptom-days" of anxiety and depression annually in the U.S., researchers projected. (Lancet Planetary Health)
Genetics play a role in risk of suicide attempt but do not fully explain the sex differences in incidence, a Swedish cohort study found. (BMJ Mental Health)
On March 19 from 4:00-5:30 PM ET NAMI will host this presentation to provide an overview of catatonia and discuss the various potential causes of catatonia, as well as the many different ways in which the syndrome may manifest.
These resources provide practical toolkits and clinical guidance.
No summary available
The Stigma Unraveled/Addiction Unmasked interprofessional workshop prompted meaningful and statistically significant changes in participant beliefs, attitudes, behaviors, and knowledge.
Active theta-burst stimulation beat sham stimulation at reducing depression scores by week 12 -- but not by week 6 -- in people with late-life depression, a randomized clinical trial showed. (American Journal of Psychiatry)
While the majority of patients with first-episode psychosis respond to initial treatment with oral risperidone or amisulpride, clozapine appeared to be the best next step for non-responders in a sequential trial. (JAMA Psychiatry)
Stimulant prescriptions for ADHD surged in adults during the COVID pandemic, a Canadian study found. (CMAJ)